(Q94340370)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2360053&resulttype=core&format=json

14 May 2020

title

Reply: The long-term response to imatinib treatment of CML (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2360053&resulttype=core&format=json

14 May 2020

1 reference

F Michor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2360053&resulttype=core&format=json

14 May 2020

publication date

6 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2360053&resulttype=core&format=json

British Journal of Cancer

14 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2360053&resulttype=core&format=json

14 May 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2360053&resulttype=core&format=json

14 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2360053&resulttype=core&format=json

14 May 2020

page(s)

679-680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2360053&resulttype=core&format=json

Leukaemia stem cells: hit or miss?

14 May 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360053

Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360053

Successful therapy must eradicate cancer stem cells.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360053

Dynamics of chronic myeloid leukaemia.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360053

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360053

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360053

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360053

BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360053

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360053

11 February 2021

Identifiers

DOI

10.1038/SJ.BJC.6603604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2360053&resulttype=core&format=json

14 May 2020

1 reference